Tag: Prescription Drugs
Novel Scoring System Can Up Access to Biologics in Psoriasis
DLQI-R allows more patients to achieve threshold for becoming candidates for biologic treatment
HIV Transmission Risk Small With Antiretroviral Compliance
No transmissions with antiretroviral tx, viral load of less than 200 copies/mL four to six months apart
Patient Education Ups VTE Prophylaxis in Hospital Setting
Targeted patient-centered intervention reduces nonadministration of pharmacologic prophylaxis
Even With Standing Orders, Naloxone Access Varies
Despite standing order legislation in two states, there is great variance in pharmacy availability
Higher Risk for Amputation, DKA With SGLT2 Inhibitors for T2DM
Risk increased for lower-limb amputation, diabetic ketoacidosis compared with GLP1 receptor agonists
Epinephrine Personal Autoinjectors Cost-Effective at $24
Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24
Option Found for Retreatment of Chronic Hep C Infection
Glecaprevir + pibrentasvir effective for those who previously failed direct-acting antiviral treatment
Name-Brand Medications Driving Spike in U.S. Drug Spending
Greatest costs for Humira, Remicade, Enbrel, Novolog, and Neulasta
Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
Intervention included educational deprescribing information to patients, physicians
Denosumab Promising for TDT-Induced Osteoporosis Treatment
Higher percentage increase of L1 to L4 and wrist bone mineral density with DMN, reduction in pain
